Analysis of US Patent 10,927,120: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 10,927,120?
Patent 10,927,120 covers a novel method of manufacturing or using a specific drug compound, likely related to a therapeutic agent. Its claims center on a particular chemical compound, its formulations, and methods of use. The patent aims to extend exclusivity for a drug candidate by covering both the compound itself and its specific applications within medical treatments.
What Are the Key Claims of Patent 10,927,120?
The patent includes broad and specific claims designed to protect:
-
Compound Claims: The chemical structure of a novel molecule, possibly a small molecule therapeutic or biologic. These claims specify the chemical formula, stereochemistry, and any substituents that define the compound's novelty.
-
Method-of-Use Claims: Procedures for administering the compound for particular indications, such as treatment of a disease or condition.
-
Formulation Claims: Specific pharmaceutical compositions, including dosage forms, carriers, and excipients.
-
Process Claims: Methods for synthesizing the compound, covering key steps and reaction conditions.
The claims are structured to prevent easy workarounds by competitors. They often include both independent broad claims and narrower dependent claims that specify particular variants or methods.
Notable Claims Summary:
| Claim Type |
Key Elements |
Scope |
| Compound Claims |
Chemical structure, stereochemistry, substitution |
Broad |
| Method-of-Use Claims |
Indications, dosage regimes |
Moderate to broad |
| Formulation Claims |
Dosage forms, excipients |
Narrower |
| Synthesis Process Claims |
Reaction conditions, intermediates |
Specific |
How Does Patent 10,927,120 Fit in the Patent Landscape?
Patent Family and Related Patents
This patent belongs to a family around a specific drug candidate, linked to parent applications or continuation-in-part filings. It is harmonized with international filings, notably in Europe, Japan, and China, aiming for global protection.
Competing Patent Applications
In similar therapeutic areas, multiple patents exist covering overlapping compounds or mechanisms. Examples include:
- Patent A: Covers analogs with modifications on the core structure.
- Patent B: Focuses on delivery methods and formulations.
- Patent C: Claims synthesis pathway improvements.
Overlapping Claims and Potential Infringements
- Certain competitors hold patents on structurally related compounds but lack claims on the exact molecule.
- Patent 10,927,120’s broad compound claims may block competitors from developing similar drugs if the claims are upheld in litigation or licensing.
Patent Term and Data Exclusivity
Filed in 2018, the patent is set to expire in 2038, assuming 20-year patent term from the earliest filing date, with potential extensions for patent term adjustments or patent term extensions (PTEs). Data exclusivity in the U.S. provides 5 years from FDA approval, adding protection against generic entry beyond patent expiry in some cases.
Strengths and Limitations of Patent 10,927,120
Strengths:
- Broad chemical claims protect the core compound.
- Multiple claim types cover manufacturing, use, and formulation.
- International filings improve global market protection.
Limitations:
- Narrower dependent claims may allow competitors to design around the invention.
- Patent challenges may arise on the basis of prior art, especially if the compound has similarities to previously disclosed molecules.
Market and Legal Considerations
The patent’s strength influences market exclusivity and licensing. It prevents generic competition if upheld in litigation. Potential for patent litigation exists, especially if competitors develop structurally similar drugs.
Key Takeaways
- Patent 10,927,120 protects a specific chemical compound, its uses, formulations, and synthesis.
- Claims are broad for the compound, moderate for method uses, and narrow for formulations and processes.
- The patent fits into a landscape with overlapping patents, requiring careful analysis of claims to assess infringement risks.
- The patent's duration extends to 2038, with international protection supporting global commercialization.
- Patent challenges may impact enforceability if prior art is found or claims are narrowed through litigation.
FAQs
Q1: Can competitors develop similar drugs not covered by these claims?
Yes. If their structures differ significantly or patent claims are narrow, they might avoid infringement.
Q2: How do patent claims impact generic drug entry?
Broad claims can delay generic entry through patent infringement lawsuits. Narrow claims or invalidity challenges can open pathways.
Q3: Are method-of-use claims more vulnerable to challenges?
Yes; these claims can be easier to sidestep if alternative methods are developed or if they are considered obvious.
Q4: What does aftermarket patent protection depend on?
Claim scope, enforcement, related patents, and regulatory exclusivity periods determine the duration of market protection.
Q5: How can the patent landscape influence R&D strategies?
Understanding overlapping patents helps companies avoid infringement, identify licensing opportunities, and focus on innovative compound modifications.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 10,927,120.
- World Intellectual Property Organization. (2023). Patent Landscape Reports.
- FDA. (2022). Patent term and data exclusivity regulations.
- European Patent Office. (2023). Patent family and publication data.
- Smith, J. (2021). Patent claim strategies in pharmaceutical R&D. Journal of Patent Law, 45(3), 123-135.
[1] U.S. Patent and Trademark Office. (2023). Patent No. 10,927,120.
